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Myosin light-chain kinaseThe frequency of cardiovascular disorders is increasing in HIV-infected individuals despite a signiﬁcant reduction
in the viral load by antiretroviral therapies (ART). Since the CD4+ T-cells are responsible for the viral load as well
as immunological responses, we hypothesized that chronic HIV-infection of T-cells produces novel proteins/
enzymes that cause cardiac dysfunctions. To identify speciﬁc factors that might cause cardiac disorders without
the inﬂuence of numerous cofactors produced by other pathogenic microorganisms that co-inhabit most HIV-
infected individuals, we analyzed genome-wide proteomes of a CD4+ T-cell line at different stages of HIV repli-
cation and cell growth over N6 months. Subtractive analyses of several hundred differentially regulated proteins
fromHIV-infected and uninfected counterpart cells and comparisonswith proteins expressed from the same cells
after treating with the antiviral drug Zidovudine/AZT and inhibiting virus replication, identiﬁed a well-
coordinated network of 12 soluble/diffusible proteins in HIV-infected cells. Functional categorization, bioinfor-
matics and statistical analyses of each protein predicted that the expression of cardiac-speciﬁc Ca2+ kinase to-
gether with multiple Ca2+ release channels causes a sustained overload of Ca2+ in the heart which induces
fetal/cardiac myosin heavy chains (MYH6 and MYH7) and a myosin light-chain kinase. Each of these proteins
has been shown to cause cardiac stress, arrhythmia, hypertrophic signaling, cardiomyopathy and heart failure
(p = 8 × 10−11). Translational studies using the newly discovered proteins produced by HIV infection alone
would provide additional biomarkers that could be added to the conventional markers for an early diagnosis
and/or development of speciﬁc therapeutic interventions for heart diseases in HIV-infected individuals.
© 2015 Rasheed et al. Published by Elsevier B.V. on behalf of the Research Network of Computational and
Structural Biotechnology. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The incidence of the acquired immunodeﬁciency syndrome (AIDS)
has been successfully halted by a combination of antiviral therapies
(ART), which suppress the human immunodeﬁciency virus (HIV)-load
in the plasma of HIV-infected patients. However, despite the reduction
of virus load, a signiﬁcant number of HIV-infected individuals develop
multiple immune-response and metabolic diseases including multiple
cardiac disorders [1,3,21,26,31,32,38,45,49]. Global studies and Data
Collection on Adverse Events of Anti-HIV Drugs (D: A:D) have indicated
that although the traditional cardiovascular risk factors such as elevated
lipid levels, diabetes and hypertension are common among both the
HIV-infected and uninfected controls, a 26% increased risk ofmyocardial
infarction and dyslipidemia could be associated to ART exposure
[14,15,67]. This phenomenon was increased among women even
when adjusted for other risk factors [17,62].1 323 227 1840.
.V. on behalf of the Research Netwo
s/by/4.0/).While many different cell types in the body are susceptible to HIV-
replication, the bulk of the virus load in the blood comes from the periph-
eralmononuclear cells including CD4+ T-cells,macrophage and dendrit-
ic cells. Earlier studies by our group had demonstrated that infants who
died of “sudden death” syndrome had signiﬁcant quantities of HIV-
infected T-cells in the heart, and HIV could be cultured from pericardial
effusions of these infants [27]. Our earlier studies had also indicated
that HIV-infected cells produce novel proteins/enzymes, which protect
the HIV-infected cells from apoptotic pathways, enhance fatty acid syn-
thesis and induce a wide range of metabolic abnormalities which are in-
volved in increased dyslipidemia in HIV-infected individuals [56].
Adult postmortem studies have also indicated that HIV-infected-
activated CD4+ T-cells are recruited in the left ventricular myocardium
in hearts from HIV-infected subjects [36]. The HIV-infected, T-cells re-
main in an activated state due to constant antigenic stimulation in
both treated and untreated individuals [2]. A subset of T-cells present
in the heart could be stained by immunocytochemistry for cyclooxygen-
ase 2 (COX-2) and inducible nitric oxide synthase, indicating that HIV-
infected T-cells present in the heart played an important role in the pro-
gression of myocarditis [36].rk of Computational and Structural Biotechnology. This is an open access article under
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cellular Ca2+ signaling and cell survival with suppression of apoptotic
pathways [4,8,9,33]. While only a brief spike of Ca2+ is needed for
most normal cellular functions, an increased intracellular calcium
(Ca2+) is essential for the contraction and relaxation of heart muscles
[6,28,64]. We therefore tested a hypothesis that HIV-infected/
activated CD4+ T-cells express abnormal protein factors/enzymes that
can infect heart tissue locally, and cause myocarditis, inﬂammatory re-
sponses and cardiac dysfunctions resulting in arrhythmia, cardiomyop-
athy and associated heart diseases.
In this report, we present experimental evidence that HIV-infection
alone can enhance a well-coordinated expression of different types of
Ca2+ release channels and kinases which have been shown to trigger
overexpression of both fast and slow cardiac/fetal myosins together
with a myosin light-chain kinase (MYH6-alpha, MYH7-beta and MYLK
respectively) that are critical for the contraction and relaxation of
heart muscles. Each of these proteins has been predicted by multiple
bioinformatics tools including the binomial probability distribution to
deﬁne the statistical signiﬁcance of proteins associated with the
development of arrhythmia, heart failures and cardiomyopathy in
HIV-uninfected population groups (p = 8 × 10−11). Inclusion of these
unconventional biomarkers with the conventional risk factors would
help in translational studies leading to early detection of HIV-
associated cardiac diseases and possibly novel therapeutic interventions
for speciﬁc disorders.2. Study Design, Materials and Methods
2.1. Cells and Virus
Amajor consideration in the design of the present study has been to
choose an in vitro system in which molecular changes in the signaling
proteins solely due to long-term HIV-infection (at least 6–7 months)
could be evaluated sequentially at different time points. While numer-
ous cell types including the freshly isolated peripheral blood mononu-
clear cells (PBMCs) or cardiomyocytes can be infected with HIV
in vitro, these cells are not suitable for long-term infections as they die
due to cytotoxicity or apoptosis within 7–10 days of infection. Further,
the cytopathic indices of HIV-infections in primary cells vary from per-
son to person due to genetic heterogeneity of human population groups
and differences in the susceptibility of different human cell types to HIV
replication (Rasheed, personal observations). We also could not con-
duct proteomics studies directly in HIV-infected individuals without
ﬁrst identifying protein proﬁles of cells infected by HIV alone, because
most HIV-patients are co-infected with other pathogenic viruses and
microorganisms that may produce factors similar to those induced by
HIV. We therefore chose a genetically stable, single-cell-clone of a
human T-cell line (RH9) [55] and infected it with a biologically cloned
North American HIV-Clade B (HBX) in vitro. The differentially-
regulated proteins expressed in HIV-infected and counterpart uninfect-
ed cells were evaluated at numerous time points from 1.5-, 3,6-, 12- and
24-h, followed by weekly, then 4–6 weeks samplings for 6–7 months
post-infection. In addition, proteomes were also studied from a
chronically-infected RH9 cell line that has been maintained in our lab
for decades as it can sustain HIV-replication for prolonged periods
in vitro without exhibiting major cytopathic effects or apoptosis [54,
56]. If these infected cultures showed excessive apoptotic cells due to
overproduction of virus particles or viral proteins (gp120, Tat), in a
crowded culture we harvested an aliquot of these cells for testing and
added 1–2 × 106 per ml uninfected RH9 cells from the same cell-stock
to maintain virus infected cultures. The uninfected cells were added to
the infected cells approximately after 2–3 months of continuously
maintaining these cells in vitro. An advantage of this regimen of analysis
was that both newly induced cellular proteins and those produced by
chronically infected cells were detected reproducibly multiple times. Ifa protein was not detected at least twice, it was not included in the
analyses.
2.2. Protein Isolation and Proteomics Analyses
We have used a rapid lysis method that was developed in our labo-
ratory several years ago [54,56]. A sequential protein extraction tech-
nique has been extremely helpful in studying the dynamics expression
of proteins associated with the plasmamembrane, extracellular matrix,
cytoplasm and nucleus. The membrane and extracellular matrix pro-
teins were isolated by lysing cells for 15 s in solution containing 8 M
Urea, 2% (w/v) CHAPS, 2% mercaptoethanol, 2.5% protease inhibitor
cocktail, and 150 units/200 μl endonuclease. Each lysate was gently
sonicated for 2 s then clariﬁed ﬁrst at 14,000 rpm followed by centrifu-
gation at high speed (100,000 ×g) for 90 min. Soluble proteins in the
supernatants were used to fractionate by 2-dimensional gradient
(6–18%) gel electrophoresis (2DE). Cell-pellets were solubilized again
with 9 M urea, 2 M thiourea and 4% CHAPS with other reagents being
the same as above. This process was repeated one more time. More
than 200 gels were evaluated and differentially expressed proteins
from HIV-infected and uninfected controls cells were compared by
using PDQuest software (BioRad). The presence or absence of each pro-
tein was conﬁrmed by the matrix-assisted laser desorption ionization
time of ﬂight mass spectrometry (MALDI-TOF-MS). Only those gel-
spots that reproducibly conﬁrmed proteins at least two times by
MALDI-TOF-MSwere included in bioinformatics and statistical analyses.
We also preferred to use MALDI-MS for this analysis than the liquid
chromatography (LC) MS because proteins of interest could be repro-
ducibly conﬁrmed by re-sampling protein spotsmanually frommultiple
gels and both the high molecular weight proteins and small peptide
fragments could be identiﬁed by MALDI-MS accurately. Thus, the spec-
iﬁcity and reproducibility ofmembrane and extracellularmatrix protein
identiﬁcations were favored in this study over the total number of pro-
teins (sensitivity) detected within a proteome.
2.3. Inhibition of Virus Replication
To validate protein expression proﬁles before and after infection,
we inhibited chronic virus replication (in RH9 cell line that was infected
for several months), by treating cells with a potent anti-reverse tran-
scriptase agent, Zidovudine/AZT for 48 h in vitro. Protein proﬁles from
HIV-infected, uninfected and AZT-treated and untreated counterpart
cells were compared with each other by the use of a software
(PDQuest-BioRad) and differentially regulated proteins in AZT-
treated/-untreated cells, with and without HIV-infection were identi-
ﬁed by mass spectrometry.
2.4. Bioinformatics and Statistical Analyses
Presence or absence of differentially expressed (upregulated, down-
regulated and de novo expressed) proteins, functional categorization,
bioinformatics and statistical analyses were conducted by the use of
multiple tools (Ingenuity Pathway Analysis (IPA) Systems, Expasy/
UniProt), and various analytical programs available through theNation-
al Center of Biotechnology Institute (NCBI), and other public databases.
The expected or E-values for all proteins associated with the calcium-
release channels and cardiac myosins are from the Global Functional
Analysis Program embedded in the IPA. The total number of proteins
that have been shown to be statistically signiﬁcant was also calculated
by using the right-tailed Fisher Exact Test and IPA systems analyses.
3. Results
Replication of HIV in CD4+ T-cell line (RH9)was highly efﬁcient and
proteomes could be analyzed sequentially in the absence of excessive
cytotoxicity or cell death. These proteins represented changes due to
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The protein expression proﬁles from HIV-infected cells were compared
with counterpart uninfected cells (with and without treatment with
antiretroviral drug Zidovudine/AZT) by subtractive proteomics analysis
and differentially expressed proteins were categorized as follows: 1) de
novo induced proteins were produced only by HIV-infected cells; 2) up-
regulated proteins are those that were expressed in uninfected control
cells in small amounts but were increased in quantity (overexpressed)
by HIV-replication and 3) proteins that are downregulated or their ex-
pressionwas completely turned off after HIV-infection. All differentially
regulated proteins between HIV-infected and uninfected cells were
identiﬁed in multiple gels and proteins that were not conﬁrmed at
least twice by mass spectrometry were discarded from the analyses.
Functional categorization of several hundred proteins identiﬁed 12
proteins that have been shown to be involved in regulating calcium
(Ca2+) homeostasis and affect heart muscle functions (MYH6 and
MYH7) (Table 1). The Ca2+ regulating proteins (n=9)were either up-
regulated or induced de novo post-HIV infection. Each of these proteins
could be divided into distinct classes of Ca2+-release channels, Ca2+
regulatory kinases, Ca2+-binding and Ca2+ cycling proteins (Table 1).
In addition, we have identiﬁed embryonic cardiac myosin heavy chains
(myosin-6 and myosin-7) and light chain myosin kinase (MYLK)
(n = 3) that were coexpressed in HIV-infected cells only but were
not detected in any of the uninfected cells or in cells that were treat-
ed with AZT. These newly identiﬁed proteins have been localized to
the extracellular matrix, plasma membrane or endoplasmic reticu-
lum although some of these proteins have been shown to shuttle
back and forth from the cytoplasm to other organelles including
the nucleus. Full names, abbreviations and accession numbers of all
proteins are according to the Swiss-PROT/Uni-PROT global databases
(Table 1).
Bioinformatics and statistical analyses of each of the 12 proteins in-
dicated that the calcium signaling proteins are critical for regulating
Ca2+ inﬂux and efﬂux; and cardiac myosins and myosin kinase are in-
volved in cardiac morphogenesis in the embryo and are essential for
controlling the contraction and relaxation of the heart muscle.
In the following sections,we have described theproperties and func-
tionalities of each of these 12 proteins and discussed their associations
with T-cell activation, Ca2+ regulation, Ca2+ signaling and developmentTable 1
HIV-modulated proteins associated with cardiovascular functions and dysfunctions.
Protein name Abbrev Accession # Function/diseases
Myosin heavy chain, cardiac muscle
alpha isoform
MYH6 P13533 “Fast” ATPase use
Myosin heavy chain, cardiac muscle
beta isoform
MYH7 P12883 “Slow” ATPase use
muscle contractio
Myosin light chain kinase, smooth
muscle and non-muscle isozymes
MYLK Q15746 Calcium/calmodu
phosphorylation o
and permeability
Ryanodine receptor 1 RYR1 P21817 Malignant hypert
insufﬁciency), arr
Ryanodine receptor 2 RYR2 Q92736 Heart failure, atria
Ryanodine receptor 3 RYR3 Q15413 Abnormal contrac
Inositol 1,4,5-trisphosphate
receptor type 1
ITPR1
(or IP3R1)
Q14643 Myocardial hyper
dysfunction and c
Inositol 1,4,5-trisphosphate
receptor type 2
ITPR2
(or IP3R2)
Q14571 Cardiac hypertrop
Sarcoplasmic/endoplasmic
reticulum calcium ATPase 2
AT2A2 (SERCA2) P16615 Abnormal contrac
cardiac death
Calumenin CALU O43852 Ca2+ binding; reg
Calcium/calmodulin-dependent
protein kinase type II alpha chain
CaMKII Q96RR4 Regulates SERCA-
Phosphatidylinositol-4-phosphate
3-kinase C2 beta
PI3K
(P3C2B)
O00750 Binds to its recept
Table 1: Full names, abbreviations, accession numbers (UniProt) and functional signiﬁcanc
dysfunctions.
All 12 proteins are located in the plasma membrane/endoplasmic reticulum membrane. An ov
contractile dysfunction, cardiac hypertrophy, ventricular arrhythmia, heart failure and/or cardiof heart diseases. Each of these proteins has been independently linked
to arrhythmia, heart failure, cardiomyopathy or sudden cardiac death
in HIV-uninfected individuals (p= 6.1 × 10−3 – 1.8 × 10−7).
3.1. Dysregulation of Calcium-release Channels and Regulatory Kinase
Calcium is an essential element for life and its expression is con-
trolled by extremely intricate mechanisms of Ca2+ release channels
and pumps embedded in the plasma membranes and endoplasmic
reticuli of all cell types in the body. While only small amounts of Ca2+
are needed for the sustenance of most cell types, the muscle and
nerve cells utilize higher amounts of Ca2+ for contraction and relaxa-
tion. Among the main Ca2+ regulatory proteins, 9 were dysregulated
during HIV-replication, and the signiﬁcance of each of these proteins
has been deﬁned in relation to the cardiac functions by multiple bioin-
formatics and statistical tools.
3.1.1. The Ryanodine Receptors or the Type-1 Calcium-Release Channels
The type-1 calcium release channels include the ryanodine receptors
RyR1, RyR2 and RyR3 that are responsible for the release of Ca2+ intra-
cellularly. While all three isomers of RyRs were detected in the HIV-
infected and uninfected CD4+ T-cells, the expression of RyR1 was the
same or very slightly downregulated (not signiﬁcant) in HIV-infected
cells compared to the uninfected control cells; and both RyR2 and
RyR3 were upregulated post-HIV-infection (Fig. 1).
The RyR2 calcium release channel was detected more frequently
(19 times) in HIV-infected T-cells compared to the uninfected counter-
part cells in which it was detected only 5-times. RyR2 is the cardiac
muscle-type receptor, which is essential for the regulation of the
excitation–contraction coupling (ECC) or the contraction and relax-
ation rhythms of the heart muscle [5,11,12].The ECC depends di-
rectly on the opening and closing of RyR-Ca2+ release channels at
speciﬁc rates while these proteins also regulate systolic and diastolic
functions of the striated cardiac and skeletal muscles [50,65,69]. RyR2
has also been shown to mediate arrhythmia and sudden-death syn-
drome [5]. RyR3 proteinmobilizes stored Ca+2 in both cardiac and skel-
etal muscle to initiate muscle contraction and dysregulation of both
RyR2 and RyR3 that have been associated with cardiac diseases [11,12].p-Value
d to hydrolyze ATP in the heart and causes high-velocity muscle 2 0.000135
d to hydrolyze ATP in the heart and causes slow-velocity
n
0.000440
lin-dependent enzyme involved in smooth muscle contraction via
f myosin light chains; essential in gap junction formation
0.000440
hermia, central core disease (increased heart rate, respiratory
hythmia, heart failure
0.000722
l ﬁbrillation, catecholaminergic polymorphic ventricular tachycardia 0.000879
tion of skeletal muscle 0.00615
trophy, leaky channels, altered calcium signaling, contractile
ardiac arrhythmias
0.00615
hy, ventricular arrhythmia, atrial ﬁbrillation 0.00615
tion/relaxation cycles, dilated cardiomyopathy, heart failure, 0.00615
ulates RYRs and coagulates blood 0.0109
related Ca2+ release Detected in
small quantities
ors ITPR1 and ITPR2; regulates myocardial contractility 0.00288
e of HIV-modulated proteins identiﬁed to be associated with cardiovascular functions
erexpression of these proteins leads to cardiac muscle damage, tachycardia, heart failure,
ac death.
0500
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Fig. 1. Proteomics analyses of Ca2+ release channels and signaling proteins; average quan-
tity of each protein detected in HIV-infected cells (blue bars) versus uninfected counter-
part controls (red bars). From left to right Type 1 Calcium Release Channels or
Ryanodine Receptors 1,2 &3.: RYR1, 2 & 3 = ITPR1 and ITPR2 followed by Type 2 Calcium
Release Channels, PI3K = phosphatidylinositol-4-phosphate 3-kinase C2 beta; SERCA =
sarcoplasmic/endoplasmic-reticulum calcium ATPase2; CALU = Calumenin, a calcium-
binding protein. ITPR1, ITPR2, PI3K, SERCA and CALU were expressed exclusively in HIV-
infected cells and were not detected in any of the numerous counterpart uninfected
cells tested.
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previously in relation to HIV-infection of T-cells, HIV infection of
T-cells is activated due to increased intracellular Ca2+ levels [33]. An in-
creased intracellular Ca2+ level in the muscles has also been shown to
affect excitation–contraction coupling in cardiac muscle in experimen-
tal mice [16]. Our proteomics and bioinformatics analyses predict that
the presence of HIV-infected-activated T-cells in the heart would en-
hance the release of Ca2+ levels in vivo and a sustained overload of cal-
ciumwould dysregulate expression of RyR2 and RyR3 in the heart. This
would conceivably be predicted to induce oxidative stress and
enhanced susceptibility to myocarditis, abnormal ECC, arrhythmia,
ventricular dysplasia, heart failure and/or hypertrophy and cell death
in HIV-infected individuals [20]. These functionalities are statistically
signiﬁcant (p= 5.0 × 10−3).
3.1.2. The Type-2 Ca2+ Release Channels or the Inositol
1,4,5-Trisphosphate Receptors
The type-2 Ca2+ release channels belong to a distinct class of inositol
1,4,5-trisphosphate receptors (ITPR1 and ITPR2; together known as
IP3Rs).While these channels have been reported to be expressed on dif-
ferent types of human and animal cells including human T-cells [60,65],
we have identiﬁed both ITPR1 and ITPR2 to be expressed exclusively in
HIV-infected cells, and these receptorswere not detected among several
thousands of protein spots tested bymass spectrometry from the unin-
fected counterpart cells at different stages of cell growth overtime
(Fig. 1). The ITPR1 enhances intracellular Ca2+ stores and has been
shown to interact with the HIV-encoded Nef protein in primary human
peripheral mononuclear cells [37].
Inositol 1,4,5-trisphosphate (IP3) is a soluble factor that binds to
IP3Rs present on the SERCA located in the endoplasmic reticulum (see
Section 3.1.3 below). IP3 also triggers the release of Ca2+ into the
cytosol and increases its quantity in the cell. Both the type 1 and type
2 classes of Ca2+ release channels (i.e. RyRs and ITPRs) are located in
close proximity of each other and therefore they are phosphorylated
during T-cell activation in the channel pore and work in harmony to
maintain and regulate cardiac rhythm [19,20,24,65]. Another study sug-
gested that primary macrophages exposed to HIV-encoded Tat protein
also release intracellular calcium from IP3-regulated calcium stores
which increases production of TNF-alpha [40]. However, these studies
have not reported detection of ITPR2, RyRs, Ca2+ regulatory kinases,
Ca2+ binding proteins identiﬁed in the present research (Fig. 1). Thus,
our bioinformatic analyses of the co-expressed type 1 and type 2 classesof Ca2+ release channels (i.e. RyR2 and ITPR2) in the T-cells and overex-
pression of PI3K and Ca2+-kinase (CamK11) (see below) and other
Ca2+ signaling or Ca2+ binding proteins would be predicted to
dysregulate Ca2+ cycling in the heart of HIV-infected individuals
(p= 10−4).
3.1.3. Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase2 (SERCA)
Sarcoplasmic/Endoplasmic Reticulum (SER) Ca2+ ATPase2 (SERCA2
or ATP2A2) was expressed exclusively in our experimentally HIV-
infected T-cells and was not detected in any of the thousands of
protein-spots tested from uninfected counterpart T-cells at various
stages of cell growth (Fig. 1). SERCA are Ca2+ ATPase pumps involved
in regulating Ca2+ release for cellular homeostasis in health and disease
[13,22,39,63]. This highly specialized ATPase controls the amount of free
calcium in cardiac muscle ﬁbers via Ca2+ release-channels that are lo-
cated in SERCA [28,33,41].
The stored Ca2+ is released from SERCA through two different clas-
ses of calcium-release channels described above (i.e. IP3R and RyRs).
Under normal conditions, Ca2+ is pumped into SERCA and is released
by IP3R or RyRs. The ratio between the expression levels of ITPRs to
RyRs is therefore important for cardiac functions. Depolarization of sar-
coplasmic/endoplasmic reticulummembrane triggers the contraction of
muscles andwhen the Ca2+ pumps re-accumulate Ca2+ in the store the
muscles relax [28,41,50]. Thus, dysregulation of SERCA causes defective
interactions with Ca2+ release channels (RyRs or ITPRs), which results
in a wide range of abnormalities in several organs including dysregulat-
ed contraction/relaxation cycles, dilated cardiomyopathy, heart failure
and cardiac death [22] (p= 0.00615).
3.1.4. Calcium/Calmodulin-dependent Serine–Threonine Protein Kinase
Type II Alpha Chain
The calcium/calmodulin-dependent serine–threonine protein ki-
nase type II alpha chain (CaMKII) was detected only once in HIV-
infected cells but in none of the counterpart uninfected cells. While
we have not included CaMK11 in any statistical analysis, our bioinfor-
matics analyses suggest that the expression of CaMKII may have been
suppressed in HIV-infected cells by the overexpression of protein kinase
C (PKC) a highly efﬁcient serine/threonine kinase thatwe described ear-
lier to be expressed exclusively in HIV-infected cells [54]. PKC could also
compensate the functions of CaMKII especially in the presence of PI3K
and multiple other kinases that were expressed concomitantly in HIV-
infected cells [54,56]. However, it has been shown that even extremely
small quantities of CaMKII can activate RyR2 by phosphorylation, which
has been implicated in arterial ﬁbrillation, cardiac arrhythmia, cardiac
hypertrophy and heart failure [35].
3.1.5. Calumenin (CALU), a Calcium-Binding Protein
Calcium-binding proteins are critical for modulating Ca2+ release
through RyRs or IP3Rs [25]. Calumenin (CALU) was upregulated exclu-
sively in HIV-infected T-cells and it was not detected in the uninfected
cells (Table 1; Fig. 1). An important characteristic of CALU is that it con-
tains six Ca2+-bindingmotifs in the amino-terminus and a tetrapeptide
His-Asp-Glu-Phe, both of which are essential for maintaining protein–
protein interactions in SERCA [58,68]. CALU is normally expressed in
the endoplasmic reticulum of many cell types as it is involved in
protein-folding and sorting in SERCA [25]. Persistent contact of cardiac
cells with Ca2+-regulatory proteins such as CALU is therefore critical
for modifying contraction-relaxation signals of the heart muscle
(p= 0.0109) [58].
3.1.6. Phosphatidylinositol-4-Phosphate 3-Kinase C2 Beta
(P3C2B/PI3Kinase)
The phosphatidylinositol-4-phosphate 3-kinase C2 beta (P3C2B)
was upregulated in HIV-infected T-cells (Fig. 1). This enzyme contains
three critical protein–protein interaction domains (phosphoinositide-3
kinases (PI3Ks), C2 and phox-homology domain) that are important
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[47,48,52,70]. PI3K is an important enzyme for normal heart functions
as it binds to its receptors ITPR1 and ITPR2, both of which were
expressed only in HIV-infected but not in uninfected T-cells (Fig. 1).
The overexpression of several different tyrosine kinases in HIV-
infected cells raises intracellular calcium concentration by activating
phospholipases which generate inositol 1,4,5-trisphosphate (ITP) [24],
that binds to its receptors. Concomitant expression of PI3K and its
interacting receptors (ITPR1 and ITPR2) in the HIV-infected T-cells are
therefore predicted to alter myocardial functions through dysregulated
Ca2+ leaks in the heart [66].
3.2. Dysregulation of Cardiac Muscle Myosin Heavy Chains and a Light
Chain Kinase
3.2.1. Cardiac Muscle Myosin Heavy Chains Alpha MYH6 and Beta MYH7
Myosins are molecular motors that form complexes with actin and
move along the actinﬁlamentswhile activatingmyosinATPases andhy-
drolyzing ATP. These interactions convert chemical energy into me-
chanical forces essential for the contraction and relaxation of muscles
[34]. While multiple myosins were expressed exclusively in HIV-
infected T-cells, two of themost prominent cardiac related myosin pro-
teins produced post-HIV-infection were fetal cardiac muscle myosin
heavy chains alpha MYH6 and beta MYH7 (also known as MHC-alpha
and MHC-beta respectively) (Fig. 2). These myosins were not detected
in numerous samples examined from uninfected T-cells or in any of
the HIV-infected cells treated with AZT. MYH6 is a “Fast” ATPase
which hydrolyzes ATP in the heart and causes high-velocitymuscle con-
traction. MYH7 is a “Slow” ATPase that is associated with slow-velocity
muscle contraction. MYH6 also uses greater amounts of energy for
shorter muscle contractionswhile MYH7 uses smaller amounts of ener-
gy for long-term contractions [34]. Thus, the cardiac energy levels de-
pend on the amount of MYH6 and MYH7 expressed and a controlled
regulation of these myosins is essential for maintaining a balanced
level of the excitation–contraction coupling.
While the exact mechanisms by which these fetal genes affect
cardiac functions are not well-understood, comparative studies in the
coexpression networks of cardiac genes in the fetal (developing) myo-
cardium, failing myocardium and cardiac hypertrophy, identiﬁed
MYH6, MYH7 and SERCA to be the most critical fetal genes to be
expressed in fetal heart and diseased tissues [10]. The fetal genes
MYH6 and MYH7, are essential for the growth and morphogenesis of
cardiac tissue during embryonic development; and an overexpression
of both MYH6 andMYH7 has been shown to be signiﬁcantly associated
with atrial septal-defects, arrhythmia, cardiomyopathy, myocarditis,0
50
100
150
200
250
300
350
400
450
500
550
600
650
700
750
800
MYH6 M
M
ea
n 
Va
lu
e
Prote
Fig. 2.Mean values of cardiac myosins. Cardiac/fetalmyosin 6 (heavy chain—fast ATPase),myos
osins and associated kinase MYLK were expressed exclusively in HIV-infected cells (i.e. not dete
cells).microvascular-dysfunctions, hypertrophy, and heart failure [7,18,46,
51]. Both cardiac hypertrophy and heart failure have been associated
with the re-activation of the set of fetal cardiac genes, which are sup-
pressed postnatally and are substituted by the adult cardiac genes
[10]. The levels of MYH6 and MYH7 expression have also been consid-
ered as markers for the severity of myopathy [23,30,43,53].
These observations and our bioinformatics analyses of differentially
regulated proteins not only validate our hypothesis that HIV induces
unique (fetal) genes MYH6 and MYH7 in chronically infected T-cells,
but also demonstrate that the upregulation of both MYH6 (alpha
MHC) and MYH7 (beta MHC) in HIV-infected cells causes an overabun-
dance of Ca2+ and ATPase in the heart muscles, accounting for the car-
diac stress and heart failure, particularly in patients whose hearts may
be inﬁltratedwith HIV-infected T-cells. These proteins could be predict-
ed to be used as unconventional biomarkers of arrhythmia and
cardiomyopathy.
3.2.2. Myosin Light Chain Kinase
Myosin light chain kinase (MYLK) is a calcium/calmodulin-
dependent enzyme which was co-expressed with MYH6 and MYH7 in
association with multiple Ca2+ release channels described above.
These proteins were expressed exclusively in HIV-infected cells but
not in the numerous uninfected cells tested (Fig. 2). The calcium/
calmodulin-dependent enzyme is involved in smooth muscle contrac-
tion via phosphorylation of myosin light chains and is essential in gap
junction formation and permeability (p = 0.000440). MYLK also
activates multiple cellular processes including muscle contraction, cell
morphology, cell movement and it affects coronary, endothelial and
microvascular dysfunctions.
Overexpression of MYLK has also been directly associated with nu-
merous abnormalities in the vasculature as it compromises the integrity
of endothelium in the coronarymicrovasculature [61]. Most important-
ly, the expression of MYLK is critical for transferring energy to MYH6
such that it can perform both smoothmuscle and non-muscle function-
alities andmaintains basal levels of contractions via phosphorylation of
cardiac myosin light chains.
3.3. Inhibition of HIV-Replication Prevents Expression of Myosins and Ca2+
Signaling Proteins
To deﬁne the speciﬁcity of HIV-modulated proteins and to validate
the relationship between HIV-replication and induction of Ca2+ signal-
ing and cardiac myosins, we treated both HIV-infected and uninfected
RH9 T-cells with Zidovudine/AZT, a potent inhibitor of reverse tran-
scriptase and HIV-replication [42,44]. Comparisons of proteomes fromYH7 MYLK (KMLS)
in Name
in 7 (heavy chain—slow ATPase) andmyosin light chain kinase (MYLK). These cardiac my-
cted in numerous samples tested from uninfected or AZT-treated infected and uninfected
Fig. 3. Calcium signaling and canonical pathwayswere constructed using Ingenuity Pathway Analyses System. Protein–protein interaction pathways showing awell-coordinated network
of interactions between proteins that were dysregulated post-HIV-infection (RYRs) or expressed exclusively in HIV-infected cells. All 12 proteins identiﬁed to be expressed or
overexpressed inHIV-infected cellwere foundwithin the calcium signaling protein–protein interaction networks. All proteins are highlighted in different colors and the symbols represent
the different families described in the following diagram.
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cated that both HIV-infected and uninfected cells treated with AZT had
distinct proﬁles not related to HIV-infected or uninfected control cells.
With the exception of small quantities of PI3K, none of the HIV-
modulatedmyosins, Ca2+ signaling cellular proteins orHIV-p24 antigen
was detected in AZT-treated, HIV-infected cells. This is not surprising
because PI3K is essential for cell-survival and it protects the AZT-
treated cells (at least for short periods) from undergoing apoptosis
[59]. These data indicate that HIV-replication was responsible for the
modulation of multiple Ca2+ regulatory proteins and enzymes thathave been previously shown to be associated with cardiac muscle
contraction.
3.4. Protein–Protein Interaction Pathways
To test if the newly discovered Ca2+ related proteins are structurally
and functionally related, we constructed protein–protein-interaction
maps using Ingenuity Pathway Analysis (IPA) bioinformatics program.
As seen in Fig. 3 all differentially regulated Ca2+ receptors and Ca2+ sig-
naling proteins identiﬁed herein interact with each other and with
151S. Rasheed et al. / Computational and Structural Biotechnology Journal 13 (2015) 145–152numerous other cellular proteins along the Ca2+ canonical pathways
that have been reported to be signiﬁcantly associated with arrhythmia,
cardiomyopathies and related disorders in different population groups
(p= 2 × 10−16).
The intracellular calcium-release and uptake are regulated by ion-
channels that are located in the plasma membrane. Activation of
membrane-bound receptors changes the membrane potential, which
can alter protein–protein interaction pathways initiated at the plasma
membrane to cytoplasm and the nucleus.We predict that abnormalities
in Ca2+ channels and dysregulation of Ca2+-cycling proteins induce a
sustained expression of cardiac fetal gene MYH6 and MYH7 which can
then cause cardiac dysfunctions, hypertrophy and heart failure that
have been linked to alterations in ECC, arrhythmia and cardiomyopathy.
4. Discussion
Most chronic diseases including cardiac disorders are multifactorial
and numerous molecular pathways are operative in the development
of these diseases. Our earlier studies had indicated that HIV replication
enhances production of free fatty acids andmany key proteins including
low density lipoproteins that disrupt normal lipid metabolism [56]. In
this report we have identiﬁed awell-coordinated network of cardiac re-
ceptors, RyR2 and RyR3, IP3Rs Ca2+ release channels, Ca2+ signaling
and regulatory proteins (Ca2+-binding proteins, enzymes, and kinases)
which induce fetal/cardiac MYH6 and MYH7 in chronically infected
CD4+ T-cells. While the ITPR1 has been shown to interact with the
HIV-encoded Nef protein in primary human peripheral mononuclear
cells [37] and HIV-encoded Tat protein has been reported to increase
IP3 and production of TNF-alpha in primary macrophages [40], none
of the other proteins has been shown previously to be associated with
HIV-infection.
Since HIV-infected CD4+ T-cells are present in the circulation and
activated T-cells are routinely recruited to the heart, a perpetual stimu-
lation of cardiac cells by abnormal Ca2+ leaks by the expression of car-
diac RyR2 and Ca2+-regulatory enzymes, would be expected to weaken
heart muscle progressively and is predicted to induce expression of car-
diac fetal genes, MYH6 and MYH7. The co-expression of these fetal
genes deteriorates cardiac muscle, and causes arrhythmia and cardio-
myopathy (p= 2 × 10−16).
Excessive Ca2+ release in the heart has also been shown to cause en-
hanced expression of numerous cytokines and chemokines post HIV-
infection and these factors promote co-infectionswith other pathogenic
viruses/microbes [29,57]. Further, numerous abnormal cellular and viral
factors (HIV envelope-gp120 and Tat proteins) released in the hearts of
HIV-infected individuals would cause oxidative stress locally and en-
hance susceptibility to myocarditis, arrhythmia, ventricular dysplasia
and heart failure (p= 5.0 × 10−3). Thus, most chronic diseases are re-
lated to multiple etiological factors that are produced by different cell
types in the body which alter our immune responses and affect the en-
tire body's metabolon.
While in vitro ﬁndings cannot be directly implicated to the develop-
ment of diseases in vivo, there is no precedence of a coordinated
expression of Ca2+ release channels, Ca2+ regulatory enzymes and em-
bryonicMYH6 andMYH7 genes/proteins in HIV-infected cells in vitro or
in vivo. This could be because we studied the dynamics of protein ex-
pression over a long period of 6–7 months and identiﬁed proteins by a
comprehensive and subtractive proteomics analyses in comparisons to
the counterpart uninfected proteomes at different time points.
Our data have been supported by published reports in experimental
animals in which MYH6 levels were signiﬁcantly upregulated concur-
rentlywith the induced tachycardia and the left ventricular hypertrophy
in mutant mice with familial hypertrophic cardiomyopathy [16]. While
MYH6 and MYH7 have been associated with myocarditis, arrhythmias,
heart failure, and related heart diseases in the non-HIV population
groups (p= 8 × 10−11), our studies have provide strong experimental
evidence that HIV infection alone, without any co-infection or treatmentcan initiate an abnormal expression of novel myosin MYH6, MYH7 &
MYLK proteins, involved in cardiomyopathy, arrhythmia and/or prema-
ture death (p= 0.000440).
Translational studies using the newly discovered Ca2+ signalingpro-
teins and cardiac/fetal myosins would lead to a better understanding of
how a new combination of clinically signiﬁcant biomarkers could
potentially be used for early diagnosis of cardiac disorders and for the
future development of targeted therapies.We propose that the speciﬁc-
ity and sensitivity of early disease detection can be enhanced by proﬁl-
ing additional unconventional molecular markers including MYH6,
MYH7, RyRs and ITPRs to study the progression of in both HIV-
infected and uninfected individuals who are at a high risk for various
cardiovascular events.
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